🚫 NOT FOR HUMAN CONSUMPTION - RESEARCH PURPOSES ONLY 🚫
These peptides are for laboratory research only and are not intended for human or animal use.
← Back to List

Retatrutide

Description

Triple GLP-1/GIP/glucagon receptor agonist with superior weight loss effects compared to semaglutide and tirzepatide

Benefits

Recommended Dosage: 0.5-12 mg weekly, gradually titrated based on tolerance

Typical Duration: Long-term therapy with medical supervision

Safety Information

Experimental compound in clinical trials. Requires medical supervision. Monitor for GI side effects and gradual dose escalation.

Storage: Refrigerate at 2-8°C, do not freeze

⚠️ Information Accuracy Notice

If the information isn't correct, please type in the name of the peptide on PubMed to find accurate studies.